Integrated Analysis of Abrocitinib for the Treatment of Adolescents with Moderate-to-Severe Atopic Dermatitis From the Phase 3 Clinical Trial Program

被引：0

作者：

Paller, Amy ^{[1
]}

Eichenfield, Lawrence F. ^{[2
]}

Cork, Michael J. ^{[3
,4
]}

Bangert, Christine ^{[5
]}

Irvine, Alan D. ^{[6
]}

Weidinger, Stephan ^{[7
]}

Johnson, Susan ^{[8
]}

Lazariciu, Irina ^{[9
]}

Koppensteiner, Herwig ^{[10
]}

机构：

[1] Northwestern Univ, Feinberg Sch Med, Chicago, IL 60611 USA

[2] UC San Diego & Rady Childrens Hosp, San Diego, CA USA

[3] Univ Sheffield, Sheffield Dermatol Res, IICD, Sheffield, S Yorkshire, England

[4] Sheffield Childrens Hosp, Sheffield, S Yorkshire, England

[5] Med Univ Vienna, Vienna, Austria

[6] Trinity Coll Dublin, St James Hosp, Sch Med, Dublin, Ireland

[7] Univ Hosp Schleswig Holstein, Kiel, Germany

[8] Pfizer Inc, Durham, England

[9] IQVIA, Kirkland, WA USA

[10] Pfizer Corp Austria Gesell mbh, Vienna, Austria

来源：

JOURNAL DER DEUTSCHEN DERMATOLOGISCHEN GESELLSCHAFT | 2023年 / 21卷

关键词：

D O I：

暂无

中图分类号：

R75 [皮肤病学与性病学];

学科分类号：

100206 ;

摘要：

P107

引用

页码：77 / 77

页数：1